Min Kan
Overview
Explore the profile of Min Kan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kan M, Wang R, Chen L, Lv X, Qiu W, Zhang H, et al.
Free Radic Biol Med
. 2024 Sep;
224:809-821.
PMID: 39265793
Alcohol-associated liver disease(ALD), caused by excessive alcohol consumption, are often associated with inflammatory outbreaks and lipid deposition in the liver. The role of Insulin-like growth factor-binding protein 7 (IGFBP7), an...
2.
Fu L, Liu X, Zhang L, Lou J, Zheng X, Wang X, et al.
Br J Ophthalmol
. 2024 Sep;
109(3):333-339.
PMID: 39251336
Purpose: To create a computational fluid dynamics (CFD) model of ocular anterior segment for primary angle closure diseases (PACD) and assess the aqueous humour (AH) dynamics in different angle closure...
3.
Chen L, Wang R, Lv X, Kan M, Zhang H, Qiu W, et al.
Biochem Pharmacol
. 2024 Jun;
226:116371.
PMID: 38885771
Clinical observations suggest that acute kidney injury (AKI) occurs in approximately 20-50% of hospitalized cirrhotic patients, suggesting a link between the liver and kidney. Bone morphogenetic protein 9 (BMP9) is...
4.
Yang X, Ye P, Liu X, Guo Z, Kan M, Li Q, et al.
Br J Clin Pharmacol
. 2023 Jan;
89(6):1862-1872.
PMID: 36662574
Aims: Apatinib is widely used in Chinese cancer patients. As the in vivo drug disposition of apatinib has large individual differences, adverse events are prone to occur. Cytochrome P450 (CYP)3A5...
5.
Liu H, Thi Q, Man P, Chen X, Chen T, Wong L, et al.
Adv Mater
. 2023 Jan;
35(14):e2210503.
PMID: 36637097
The scalable 2D device fabrication and integration demand either the large-area synthesis or the post-synthesis transfer of 2D layers. While the direct synthesis of 2D materials on most targeted surfaces...
6.
Chen L, Lv X, Kan M, Wang R, Wang H, Zang H
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293317
Non-alcoholic fatty liver disease (NAFLD) is defined as a combination of a group of progressive diseases, presenting different structural features of the liver at different stages of the disease. According...
7.
Chen X, Liu Q, Yang J, Kan M, Jin R, Pu T, et al.
Phytother Res
. 2021 Sep;
35(11):6401-6416.
PMID: 34585457
Although renal fibrosis is a common complication of chronic kidney disease (CKD), effective options for its treatment are currently limited. In this study, we evaluated the renal protective effect and...
8.
Liu Q, Chen X, Kan M, Yang J, Gong Q, Jin R, et al.
Eur J Pharmacol
. 2021 Sep;
910:174501.
PMID: 34529980
Renal fibrosis is the main pathological feature of the occurrence and development of chronic nephropathy. At present, there is no effective treatment, except for renal transplantation and dialysis. Previous studies...
9.
Zheng Y, Ye P, Zhou Y, Wu S, Liu X, Du B, et al.
J Inflamm Res
. 2021 Aug;
14:3697-3706.
PMID: 34377007
Purpose: Inflammation has a significant impact on CYP3A activity. We hypothesized that this effect might be age dependent. Our objective was to conduct a population pharmacokinetic study of midazolam in...
10.
Xu Y, Zhang Y, Zhang Q, Zhao Q, Cao X, Zhang M, et al.
Br J Clin Pharmacol
. 2021 Feb;
87(9):3599-3607.
PMID: 33576060
Aims: Recently, letrozole has been used off-label to treat short pubertal boys. The experience on letrozole effectiveness and safety has been obtained primarily from Caucasian children. A simple extrapolation of...